SLP

The headline -$64.7M net loss and -81.7% net margin look catastrophic, but they are almost entirely a non-cash accounting event: the MD&A shows a $77.2M impairment charge inside operating expenses. Strip it out and operating expenses were ~$39.7M against $46.2M gross profit — roughly $6.5M of underlying operating income, and the business still generated $18.1M of operating cash flow (up 36.1%) against just $713K of capex. This is not a company in financial distress. The balance sheet is pristine: $125M equity against only $7.13M total liabilities (0.06x), cash of $30.9M (up 199%), and effectively no debt. On those facts alone SLP is clearly investable.

The problem is what the impairment implies. Management's own revenue bridge is damning: the entire $9.2M (13%) revenue increase to $79.2M came from a full year of the Pro-ficiency acquisition ($11.7M vs. $2.3M prior year). That means the legacy MIDD software franchise — historically the quality growth engine, with net income steady near $10M in FY2022-FY2024 — was roughly flat organically, and the very acquisition that propped up the top line is the asset now being written down $77.2M. Gross margin also slipped from 62% to 58.4% as amortization of acquired technology and pass-through service costs rose. So the story is a high-quality, cash-generative, debt-free niche software business whose growth has stalled and whose one big capital-allocation bet disappointed.